| Gynaecology Exercise and Mindfulness Study (NCT05561413) | University of Ulster | 2022-06-14 |
| Interventions to Decrease Financial Toxicity (NCT05939440) | University of Alabama at Birmingham | 2022-06-01 |
| Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer (NCT05395962) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2022-04-08 |
| MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer (NCT06273501) | Sahlgrenska University Hospital | 2022-03-24 |
| Clinical Implementation of Surface-guided Radiation Therapy in Vulvar Cancer (NCT05853549) | Peking Union Medical College Hospital | 2022-03-18 |
| Retrospective Study of Brachytherapy (NCT05242861) | Zhejiang Cancer Hospital | 2022-02-20 |
| Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer (NCT05255393) | Memorial Sloan Kettering Cancer Center | 2022-02-15 |
| Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types (NCT05000294) | University of Florida | 2021-12-07 |
| Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study (NCT04952961) | University of Manchester | 2021-11-04 |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers (NCT04708470) | National Cancer Institute (NCI) | 2021-10-05 |
| Electrochemotherapy for Recurrent Vulvar Cancer (NCT07443475) | Institute of Oncology Ljubljana | 2021-09-01 |
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-05-28 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Education, Immigration and HPV Vaccination: an Informational Randomized Trial (NCT04905030) | Karolinska Institutet | 2021-04-28 |
| Electrochemotherapy for the Treatment of Vulvar Cancer (NCT05916690) | Institute of Oncology Ljubljana | 2021-03-01 |
| Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. (NCT03061435) | Dr. Danielle Vicus | 2021-02-01 |
| Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (NCT05076942) | University Medical Center Groningen | 2021-01-01 |
| Relational Agents in Cervical Cancer Education (RACE) (NCT06537687) | Radhika Gogoi | 2020-11-18 |
| A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation (NCT04141449) | Brigham and Women's Hospital | 2020-11-18 |
| Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations (NCT04357873) | UNICANCER | 2020-10-28 |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-09-19 |
| Cisplatin+Pembrolizumab+RT in Vulvar Cancer (NCT04430699) | Massachusetts General Hospital | 2020-07-29 |
| Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer (NCT04663412) | Azienda Ospedaliera per l'Emergenza Canizzaro | 2020-07-09 |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-05-28 |
| Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-04-28 |
| Serial MRI Scans During Radiation Therapy (NCT04188535) | Dana-Farber Cancer Institute | 2020-01-15 |
| The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study (NCT04122235) | Sorlandet Hospital HF | 2019-11-18 |
| Paclitaxel Therapeutic Drug Monitoring in Cancer Patients (NCT03987555) | Wake Forest University Health Sciences | 2019-11-11 |
| Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer (NCT04152512) | Karolinska University Hospital | 2019-08-29 |
| OCT-AF Imaging of Pre-cancers of Vulva and Cervix (NCT03285841) | British Columbia Cancer Agency | 2019-07-25 |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101) | Shanghai Bovax Biotechnology Co., Ltd. | 2018-10-10 |
| Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers (NCT03403465) | Duke University | 2018-03-27 |
| Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) (NCT03158220) | Merck Sharp & Dohme LLC | 2017-09-20 |
| CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas (NCT02981862) | Institut de Cancérologie de Lorraine | 2016-12-19 |
| Image-Guided Gynecologic Brachytherapy (NCT02993900) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-12-15 |
| Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma (NCT02988765) | Catholic University of the Sacred Heart | 2016-12-01 |
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life (NCT03000192) | University Hospital Southampton NHS Foundation Trust | 2016-08-01 |
| MR-HIFU for Recurrent Gynaecological Cancer (NCT02714621) | Institute of Cancer Research, United Kingdom | 2016-05-01 |
| Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) (NCT02653118) | Merck Sharp & Dohme LLC | 2016-01-22 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer (NCT02096783) | University of Wisconsin, Madison | 2014-09-01 |
| The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence (NCT01986725) | St.Gallen University of Applied Sciences | 2013-09-01 |
| Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy (NCT02969278) | Catholic University of the Sacred Heart | 2013-07-01 |
| Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer (NCT04105465) | Royal Surrey County Hospital NHS Foundation Trust | 2013-07-01 |
| A Survivorship Care Plan for Gynaecological Cancer Patients (NCT01582906) | Royal Marsden NHS Foundation Trust | 2011-08-01 |
| Validation of a Nutrition Screening Tool (NCT01851928) | Royal Marsden NHS Foundation Trust | 2011-07-01 |
| Pelvic Floor Disorders in Survivors of Gynecologic Malignancies (NCT01370122) | Abramson Cancer Center at Penn Medicine | 2011-05-01 |
| A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer (NCT01321697) | University of Arkansas | 2011-03-01 |
| Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer (NCT01216813) | Royal Marsden NHS Foundation Trust | 2010-08-01 |
| Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors (NCT01806350) | New Mexico Cancer Research Alliance | 2009-11-01 |
| A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) (NCT00943722) | Merck Sharp & Dohme LLC | 2009-08-27 |
| Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer (NCT01526486) | Emory University | 2009-06-01 |
| Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life (NCT00870233) | Memorial Sloan Kettering Cancer Center | 2009-03-24 |
| Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer (NCT00905658) | Centre Oscar Lambret | 2008-06-01 |
| Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers (NCT00773071) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2008-04-01 |
| A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) (NCT00551187) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) (NCT00520598) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) (NCT00543543) | Merck Sharp & Dohme LLC | 2007-09-24 |
| Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva (NCT00504023) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer (NCT00381888) | Masonic Cancer Center, University of Minnesota | 2007-01-01 |
| ChemoFx® PRO - A Post-Market Data Collection Study (NCT00669422) | Precision Therapeutics | 2006-10-01 |
| Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) (NCT00851643) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer (NCT00601406) | The Christie NHS Foundation Trust | 2006-03-01 |
| Chemoradiation-Induced Nausea and Emesis: Quality of Life (NCT00394602) | M.D. Anderson Cancer Center | 2004-04-07 |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer (NCT00287885) | Masonic Cancer Center, University of Minnesota | 2004-03-01 |
| Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. (NCT00315159) | Women and Infants Hospital of Rhode Island | 2003-08-01 |
| Effectiveness of an Individualized Symptom Education Program (ISEP) (NCT00275353) | University of Toronto | 2003-07-01 |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (NCT00033605) | Alliance for Clinical Trials in Oncology | 2002-04-01 |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva (NCT00006096) | Gynecologic Oncology Group | 2001-03-01 |
| Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva (NCT00014599) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-02-01 |
| Specimen and Data Study for Ovarian Cancer Early Detection and Prevention (NCT00005095) | Northwestern University | 2000-03-01 |
| Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva (NCT00003325) | Gynecologic Oncology Group | 1999-12-01 |
| Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer (NCT00019110) | National Cancer Institute (NCI) | 1995-11-01 |
| Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph Nodes (NCT00898352) | Gynecologic Oncology Group | |
| Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox. (NCT00382330) | University of Medicine and Dentistry of New Jersey | |